r personal use only
(ASX: ANP)
AGM Presentation
December 2021
only | Forward Looking Statements |
This presentation contains forward‐looking statements regarding the Company's business & the therapeutic & commercial |
usepotential of its technologies & products in development. Any statement describing the Company's goals, expectations, intentions or beliefs is a forward‐looking statement & should be considered an at‐risk statement. Such statements are subject to certain risks & uncertainties, particularly those risks or uncertainties inherent in the process of developing technology & in the process of discovering, developing & commercializing drugs that can be proven to be safe & effective for use as human therapeutics, & in the endeavor of building a business around such products & services. Actual results could differ materially
from those discussed in this presentation. Factors that could cause or contribute to such differences include, but are not limited personalr
to, those discussed in the Antisense Therapeutics Limited Annual Report for the year ended 30 June 2021, which is available from the Company or at www.antisense.com.au.
2
r personal use only
Charmaine Gittleson MD
Board Chair
3
r personal use only
ANP Corporate Video
4
r personal use only
Key Strategic Factors for ANP Success
Expand on
value
proposition
Refine ANP | Deliver on | Leverage |
business | ATL1102 | research |
model | promise | for future |
Leverage expertise
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Antisense Therapeutics Limited published this content on 14 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 December 2021 23:28:05 UTC.